63 research outputs found
A Mixed Apocrine Gland Tumor with Metastases to the Bone and Bone Marrow in a Miniature Poodle
A 10-year-old female miniature poodle had a mass in its carpal joint of the left
forelimb. The tumor was divided into small multiple lobules by delicate
connective tissues, and necroses were found in some of the central lobules. In
some connective stromal areas, chondroid and osteoid tissues were formed. The
tumor cells were similar to the structure of apocrine gland epithelial cells
with apical blebs resembling apocrine secretion and eosinophilic secretary
materials within the luminal space, and spindle cells were sometimes found in
the basal area of the glandular structure. In some areas, tumor cells invaded in
the blood vessels, bone and bone marrow. Immunohistochemically, the tumor cells
forming tubulo-acinar to solid structures were intensely positive for
cytokeratin and keratin K8/K18, and the spindle cells were positive for vimentin
and alpha-smooth muscle actin. This case was diagnosed as a malignant mixed
apocrine gland tumor with metastases to the bone and bone marrow
A Neuroendocrine Carcinoma of Undetermined Origin in a Dog
In this report, we describe a case of neuroendocrine carcinoma of undetermined
origin in a dog. Necropsy revealed scattered small neoplastic nodules in the
bilateral lungs and a small nodule in the parapancreatic lymph node.
Histopathologically, both pulmonary and lymph nodal nodules showed a similar
histologic pattern, with neoplastic cells being arranged in diffusely
proliferating sheet-like cellular nests separated by variable amounts of fibrous
septa, sometimes forming rosettes and duct-like structures. Scattered small
necrotic foci and invasion to fibrous septa were typically observed. Neoplastic
cells showed round to oval-shaped nuclei with prominent nucleoli and abundant
eosinophilic cytoplasm that were positive for Grimelius’ silver impregnation
staining and immunostaining with cytokeratin, synaptophysin, vasoactive
intestinal peptide and chromogranin A, indicative of the development of a
neuroendocrine carcinoma. However, judging from the distribution of tumors
lacking the portion suggestive of the primary site in any organ examined, as
well as no further indication of differentiation potential of neoplastic cells,
this tumor has so far been diagnosed as neuroendocrine carcinoma of undetermined
origin
Effectiveness of an erbium-doped:yttrium, aluminum and garnet laser for treatment of peri-implant disease : clinical, microbiological, and biochemical marker analyses
The effectiveness of an erbium-doped: yttrium, aluminum and garnet (Er: YAG) laser (EYL) for the treatment of peri-implant disease (PID) remains unclear. The aim of this study was to compare non-surgical EYL therapy for PID with locally delivered minocycline hydrochloride (MC) ointment therapy by evaluating clinical, microbiological, and biochemical markers. Thirty-seven patients with PID were randomly assigned to either the EYL group (n = 18) or the MC group (n = 19). The clinical, microbiological, and biochemical markers at baseline and at 1 and 3 months after treatment were compared between the two groups. Subgingival plaque and peri-implant crevicular fluid (PICF) were collected from the diseased pockets. In the EYL group, probing pocket depth (PPD) was significantly decreased after treatment when compared with baseline. On the other hand, in the MC group, there was no significant decrease in PPD after treatment. Specific bacteria associated with PID were not determined. The counts of both Gram-positive and -negative species did not significantly decrease in the EYL group at 3 months after treatment. In the MC group, the counts of almost all bacterial species were significantly decreased after treatment. Biochemical marker analysis of PICF revealed significantly lower levels of metalloproteinase (MMP)-9 in the EYL group, as compared with the MC group at 3 months after treatment (p= 0.009). Non-surgical therapy with an EYL for PID was clinically effective, with decreased MMP-9 levels in PICF, which may lead to reduced peri-implant tissue destruction
Molecular imaging of aberrant crypt foci in the human colon targeting glutathione S-transferase P1-1
Aberrant crypt foci (ACF), the earliest precursor lesion of colorectal cancers (CRCs), are a good surrogate marker for CRC risk stratification and chemoprevention. However, the conventional ACF detection method with dye-spraying by magnifying colonoscopy is labor- and skill-intensive. We sought to identify rat and human ACF using a fluorescent imaging technique that targets a molecule specific for ACF. We found that glutathione S-transferase (GST) P1-1 was overexpressed in ACF tissues in a screening experiment. We then synthesized the fluorogenic probe, DNAT-Me, which is fluorescently quenched but is activated by GSTP1-1. A CRC cell line incubated with DNAT-Me showed strong fluorescence in the cytosol. Fluorescence intensities correlated significantly with GST activities in cancer cell lines. When we sprayed DNAT-Me onto colorectal mucosa excised from azoxymethane-treated rats and surgically resected from CRC patients, ACF with strong fluorescent signals were clearly observed. The ACF number determined by postoperative DNAT-Me imaging was almost identical to that determined by preoperative methylene blue staining. The signal-to-noise ratio for ACF in DNAT-Me images was significantly higher than that in methylene blue staining. Thus, we sensitively visualized ACF on rat and human colorectal mucosa by using a GST-activated fluorogenic probe without dye-spraying and magnifying colonoscopy
Paradoxical development of polymyositis-like autoimmunity through augmented expression of autoimmune regulator (AIRE)
Autoimmunity is prevented by the function of the autoimmune regulator [AIRE (Aire in mice)], which promotes the expression of a wide variety of tissue-restricted antigens (TRAs) from medullary thymic epithelial cells (mTECs) and from a subset of peripheral antigen-presenting cells (APCs). We examined the effect of additive expression of human AIRE (huAIRE) in a model of autoimmune diabetes in NOD mice. Unexpectedly, we observed that mice expressing augmented AIRE/Aire developed muscle-specific autoimmunity associated with incomplete maturation of mTECs together with impaired expression of Aire-dependent TRAs. This led to failure of deletion of autoreactive T cells together with dramatically reduced production of regulatory T cells in the thymus. In peripheral APCs, expression of costimulatory molecules was augmented. We suggest that levels of Aire expression need to be tightly controlled for maintenance of immunological tolerance. Our results also highlight the importance of coordinated action between central tolerance and peripheral tolerance under the common control of Aire
Constructing A New Science Framework In Japanese Historical Studies Through Digital Infrastructure
Abstract and poster of paper 0231 presented at the Digital Humanities Conference 2019 (DH2019), Utrecht , the Netherlands 9-12 July, 2019
Acute renal failure in an adult cat following oral administration of fosfomycin
Case summary A spayed female mixed breed cat of unknown age (presumably more than 9 years old), weighing 2.9 kg, was presented with a 4 day history of lethargy, anorexia and vomiting following oral administration of calcium fosfomycin (20 mg/kg q12h). A serum biochemical analysis revealed a dramatic increase in the levels of blood urea nitrogen (>140 mg/dl) and creatinine (15.3 mg/dl), and hypercalcaemia (13.1 mg/dl), hyperphosphataemia (13.3 mg/dl) and hyperkalaemia (6.1 mmol/l). The cat was hospitalised and treated with infusion therapy. However, the renal function and clinical signs did not improve with any treatment. The cat was euthanased upon the owner’s request. Histopathological analysis of the kidneys revealed acute tubular necrosis in the cortex. Relevance and novel information The present case report provides, for the first time, clinical and histopathological evidence for acute renal failure induced by oral administration of fosfomycin in an adult cat. It is highly advisable that fosfomycin should not be used in either young or adult cats
- …